Abstract | AIMS: METHODS AND RESULTS: To study the effects of acquired cardiac ATGL deficiency on cardiac PPARα activity, function, and metabolism, we generated adult mice with tamoxifen-inducible cardiomyocyte-specific ATGL deficiency (icAtglKO). Within 4-6 weeks following ATGL ablation, icAtglKO mice had markedly increased myocardial TAG accumulation, fibrotic remodelling, and pathological hypertrophy. Echocardiographic analysis of hearts in vivo revealed that contractile function was moderately reduced in icAtglKO mice. Analysis of energy metabolism in ex vivo perfused working hearts showed diminished FAO rates which was not paralleled by markedly impaired PPARα target gene expression. CONCLUSIONS: This study shows that acquired cardiomyocyte-specific ATGL deficiency in adult mice is sufficient to promote fibrotic and hypertrophic cardiomyopathy and impair myocardial FAO in the absence of markedly reduced PPARα signalling.
|
Authors | Petra C Kienesberger, Thomas Pulinilkunnil, Jeevan Nagendran, Martin E Young, Juliane G Bogner-Strauss, Hubert Hackl, Rammy Khadour, Emma Heydari, Guenter Haemmerle, Rudolf Zechner, Erin E Kershaw, Jason R B Dyck |
Journal | Cardiovascular research
(Cardiovasc Res)
Vol. 99
Issue 3
Pg. 442-51
(Aug 01 2013)
ISSN: 1755-3245 [Electronic] England |
PMID | 23708736
(Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Fatty Acids
- PPAR alpha
- Lipase
- PNPLA2 protein, mouse
|
Topics |
- Animals
- Cardiomyopathies
(metabolism, pathology, physiopathology)
- Disease Models, Animal
- Fatty Acids
(metabolism)
- Lipase
(deficiency, genetics, metabolism)
- Mice
- Mice, Inbred C57BL
- Mice, Knockout
- Mitochondria, Heart
(metabolism)
- Myocytes, Cardiac
(metabolism)
- Oxidation-Reduction
- PPAR alpha
(metabolism)
- Signal Transduction
|